February 15, 2017 / 11:25 AM / 3 years ago

BRIEF-Tianjin Tianyao's share trade to halt pending regulatory review of acquisition plan

1 Min Read

Feb 15 (Reuters) - Tianjin Tianyao Pharmaceuticals Co Ltd

* Says share trade to halt from Feb 16 pending regulatory review of its asset acquisition proposal

Source text in Chinese: bit.ly/2lOGI0R

Further company coverage: (Reporting by Hong Kong newsroom)

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below